Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

被引：0
作者：
Jabbour, Elias [1 ]
Lin, Jay [2 ]
Siegartel, Lisa R. [3 ]
Lingohr-Smith, Melissa [2 ]
Menges, Brandy [2 ]
Makenbaeva, Dinara [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Novosys Hlth, Green Brook, NJ USA
[3] Bristol Myers Squibb, Plainsboro, NJ 08536 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3573.3573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3573
引用
收藏
页数：5
相关论文
共 50 条
[21]   HIGHER RESOURCE UTILIZATION AND HEALTHCARE COSTS IN TREATED CHRONIC HEPATITIS B PATIENTS WITH CHRONIC KIDNEY DISEASE [J].
Nguyen, Mindie H. ;
Lim, Joseph K. ;
Liou, Iris ;
Fraysse, Jeremy ;
Meyer, Nicole ;
Dusheiko, Geoffrey ;
Gordon, Stuart C. .
GASTROENTEROLOGY, 2017, 152 (05) :S1087-S1087
[22]   Time to Next Treatment, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following FirstLine Ibrutinib [J].
Challagulla, Swetha ;
Emond, Bruno ;
Volodarsky, Raisa R. ;
Young, Alex ;
Manceur, Ameur ;
Karve, Sudeep .
BLOOD, 2021, 138
[23]   Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization [J].
Desai, Urvi ;
Kharat, Akshay ;
Hess, Connie N. ;
Milentijevic, Dejan ;
Laliberte, Francois ;
Zuckerman, Peter ;
Benson, John ;
Lefebvre, Patrick ;
Hiatt, William R. ;
Bonaca, Marc P. .
JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) :402-409
[24]   Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity [J].
Murage, Mwangi J. ;
Anderson, Amanda ;
Oliveria, Susan A. ;
Casso, Deborah ;
Ojeh, Clement K. ;
Muram, Talia M. ;
Merola, Joseph F. ;
Araujo, Andre B. .
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) :745-754
[25]   Real world treatment patterns, adverse events and healthcare resource utilization and costs among chronic lymphocytic leukemia (CLL) patients in the US [J].
Kabadi, Shaum ;
Olufade, Temitope O. ;
Le, Lisa ;
Byfield, Stacey Dacosta .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 :78-79
[26]   HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH MULTIPLE SWITCHING OF TYROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA [J].
Kropf, P. ;
Barnes, G. ;
Tang, B. ;
Pathak, A. ;
Issa, J. .
VALUE IN HEALTH, 2015, 18 (03) :A199-A199
[27]   Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy [J].
Huggar, David ;
Knoth, Russell L. ;
Copher, Ronda ;
Cao, Zhun ;
Lipkin, Craig ;
McBride, Ali ;
LeBlanc, Thomas W. .
BLOOD, 2021, 138
[28]   Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study [J].
Hudesman, David P. ;
Chakravarty, Soumya D. ;
Emond, Bruno ;
Ellis, Lorie A. ;
Lefebvre, Patrick ;
Sadik, Kay ;
Scher, Jose U. .
BMC RHEUMATOLOGY, 2020, 4 (01)
[29]   Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study [J].
David P. Hudesman ;
Soumya D. Chakravarty ;
Bruno Emond ;
Lorie A. Ellis ;
Patrick Lefebvre ;
Kay Sadik ;
Jose U. Scher .
BMC Rheumatology, 4
[30]   HEALTHCARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS AMONG ADULT PATIENTS WITH CHRONIC HEPATITIS C IN CHINA [J].
Wei, L. ;
Yu, N. ;
Gao, S. ;
Wang, Q. .
VALUE IN HEALTH, 2018, 21 :S87-S87
12345